Monday, October 5, 2026
26.4 C
Bengaluru

Ashok Nair, Managing Director of Abbott India in Conversation with MedicinMan

https://www.credoweb.in/discussion/661/new-growth-drivers-for-indian-pharma-companies

Ashok Nair began his career as a Medical Rep and rose to become the Managing Director of one of India's most admired pharma companies - Abbott India.

In this conversation, Ashok Nair shares his perspectives on the challenges ahead and what Indian Pharma needs to do, to face them effectively.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

This MedicinMan Intelligence Report follows a disturbing trail—from Arun...

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

With over three decades of experience in the pharmaceutical...

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

India’s anaemia challenge is not simply about access to...

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

Topics

spot_img

Related Articles

spot_imgspot_img